TMDX TransMedics
- 89.250
- +0.370+0.42%
TransMedics News
TransMedics Gr Analyst Ratings
TransMedics Group: Operational Efficiency and Market Positioning Propel Buy Rating
Oppenheimer Sticks to Its Buy Rating for TransMedics Group (TMDX)
TransMedics Gr Analyst Ratings
Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), TransMedics Group (TMDX) and MoonLake Immunotherapeutics (MLTX)
Buy Rating on TransMedics Group Amidst Growing Organ Transplant Market
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF), TransMedics Group (TMDX) and Argenx Se (ARGX)
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), TransMedics Group (TMDX) and Apellis Pharmaceuticals (APLS)
TransMedics Gr Analyst Ratings
Morgan Stanley Adjusts TransMedics Group Price Target to $75 From $54, Maintains Equal Weight Rating
TransMedics Group: Upward Revenue Guidance, Strong Sales Growth, and Emerging Aviation Sector Drive 'Buy' Rating
JP Morgan Maintains Overweight on TransMedics Gr, Raises Price Target to $70
TransMedics Gr Analyst Ratings
Morgan Stanley Maintains Equal-Weight on TransMedics Gr, Raises Price Target to $54
TransMedics Gr Analyst Ratings
Oppenheimer Keeps Their Buy Rating on TransMedics Group (TMDX)
Morgan Stanley Maintains Equal-Weight on TransMedics Gr, Lowers Price Target to $50
TransMedics Gr Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: TransMedics Group (TMDX), Modular Medical (MODD)
TD Cowen Maintains Outperform on TransMedics Gr, Raises Price Target to $110
Analysis
Price Target
No Data
